The role of diacylglycerol and activation of protein kinase C in α1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 224-230

  Burt, Richard P ^a   Chapple, Christopher R ^b   Marshall, Ian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Calphostin c; Cyclopiazonic acid; Extracellular ca2+; Nifedipine; Noradrenaline; Phorbol ester; Protein kinase c; R 59022; Rat vas deferens; 1 adrenoceptors

Indexed keywords

1,6 HEXAMETHYLENEDICARBAMIC ACID BIS(CYCLOHEXANONE OXIME) ESTER; 6 [2 [4 [(4 FLUOROPHENYL)PHENYLMETHYLENE] 1 PIPERIDYL]ETHYL] 7 METHYL 5H THIAZOLO[3,2 A]PYRIMIDIN 5 ONE; ALPHA 1A ADRENERGIC RECEPTOR; CALCIUM ION; CALPHOSTIN C; CYCLOPIAZONIC ACID; DIACYLGLYCEROL; EGTAZIC ACID; NIFEDIPINE; NORADRENALIN; PHORBOL DIBUTYRATE; PROTEIN KINASE C; RYANODINE; STAUROSPORINE;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; VAS DEFERENS;

ANIMALS; CALCIUM; CARCINOGENS; CYCLOHEXANONES; DIGLYCERIDES; LIPOPROTEIN LIPASE; MALE; NAPHTHALENES; NOREPINEPHRINE; PHORBOL 12,13-DIBUTYRATE; PLATELET ACTIVATING FACTOR; PROTEIN KINASE C; PYRIMIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; STAUROSPORINE; THIAZOLES; VAS DEFERENS;

EID: 0030069608     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15178.x     Document Type: Article

References (39)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br. J. Pharmacol., 109, 80-87.
2. ABRAHAM, S.T. & RICE, P.J. (1992). Protein kinase C-mediated contractile response of the rat vus deferens. Eur. J. Pharmacol., 218, 243-249.
3. BERRIDGE, M.J. (1993). Inositol trisphosphate and calcium signalling. Nature, 361, 315-325.
4. BISHOP, W.R. & BELL, R.W. (1986). Attenuation of sn-1,2-diacylglycerol second messenger: metabolism of exogenous diacylglycerols by human platelets. J. Biol. Chem., 261, 12513-12519.
5. BOURREAU, J.P., ZHANG, Z.D., LOW, M., KWAN, Y. & DANIEL, E.E. (1991). Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies. J. Pharmacol. Exp. Ther., 256, 1063-1071.
6. BRUNS, R.F., MILLER, F.D., MHRRIMAN, R.L. HOWBFRI, J.J., HEATH, W.F., KOBAYASHI, E. & TAKAHASHI, I. (1991). Inhibition of protein kinase C by calphostin C is light-dependent. Biochem. Biophys. Res. Commun., 176, 288-293.
7. 2+ sources. Br. J. Pharmacol., 108, 1062-1070.
8. 2 receptor signal transduction mechanisms in epididymal and prostatic ends of the rat vas deferens. Br. J. Pharmacol., 108, 61P.
9. 1B-adrenoceptor mediated contraction of the rat spleen. Br. J. Pharmacol., 115, 467-475.
10. 1B-adrenoceptor mediated contractions to phenylephrine in the rat spleen. Br. J. Pharmacol., 116, 2327-2333.
11. CASTAGNA, M., TAKAI, Y., KAIBUCHI, K., SANO, K., KIKKAWA, U. & NISHIZUKA, Y. (1982). Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor promoting phorbol esters. J. Biol. Chem., 257, 7847.
12. de CHAFFOY de COURCELLES, D., ROEVENS, P. & VAN BELLE, H. (1985). R59022, a diacyl glycerol kinase inhibitor. J. Biol. Chem., 260, 15762-15770.
13. 2+-pump inhibitor of rat aortic muscle. Acta Pharmacol. Sin., 12, 53.
14. 2+-release channels. Trends Pharmacol., 15, 145-149.
15. 2+ influx: how many mechanisms for how many channels? Trench Pharmacol. Sci., 15, 77-83.
16. FORD, D.A., MIYAKE, R., GLASFR, P.F. & GROSS, R.W. (1989). Activation of protein kinase C by naturally occurring ether-linked diglycerides. J. Biol. Chem., 264, 13818-13824.
17. 3H-inositol metabolism in rat vas deferens and caudal artery. Eur. J. Pharmacol., 116, 145-152.
18. 1-adrenoceptors. Eur. J. Pharmacol., 272, R5-R6.
19. HALLER, H., SMALLWOOD, J.I. & RASMUSSFN, H. (1990). Protein kinase C translocation in intact vasculature smooth muscle strips. Biochem. J., 270, 375-381.
20. 2+ in smooth muscle. Nature, 329, 333-335.
21. INOUE, M., KISHIMOTO, A., TAKAI, Y. & NISHIZUKA, Y. (1977). Studies in a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. J. Biol. Chem., 252, 7910.
22. 2+ mobilization and tension in arterial smooth muscle of the rabbit. J Physiol., 457, 297-314.
23. KANOH, H., SAKANE, F., SHIN-ICHI, I. & WADA, I. (1993). Diacylglycerol kinase and phosphatidic acid phosphatase-enzymes metabolizing lipid second messengers. Cell Signalling, 5, 495-503.
24. KOBAYASHI, E., NAKANO, H., MORIMOTO, M, & TAMAOKI, T. (1989). Calphostin C (UCN-1028c), A novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 159, 548-553.
25. LEE, M.W. & SEVERSON, D.L. (1994). Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am. J Physiol., 267, C659-678.
26. 1c-)adrenoceptor subtype. Br. J. Pharmacol., 115, 781-786.
27. MERKEL, L.A., RIVERA, L.M., COLUSSI, D.J. & PERRONE, M.H. (1991). Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation. J. Pharmacol. Exp. Ther., 257, 134.
28. 1-Adrenergic receptor subtypes. Annu. Rev. Pharmacol. Toxicol., 34, 117-133.
29. NISHIZUKA, Y. (1986). Studies and perspectives of protein kinase C. Science, 233, 305-312.
30. PUTNEY, J.W., Jr. (1986). A model for receptor-regulated calcium entry. Cell Calcium., 7, 1-12.
31. PUTNEY, J.W., Jr. (1990). Capacitative calcium entry revisited. Cell Calcium, 11, 611-624.
32. 1, γ, δ and ε by phorbol esters of different biological activities. FEBS Lett., 288, 5-9.
33. 2+ -ATPase of sarcoplasmic reticulum. J. Biol. Chem., 264, 17816.
34. SEVERSON, D.I., & HEE-CHEONG, M. (1986). Diacylglycerol lipase and kinase activities in rabbit aorta and coronary microvessels. Biochem. Cell Biol., 64, 976-983.
35. SHIMAMOTO, Y., SHIMAMOTO, H., KWAN, C-Y. & DANIEL, E.E. (1993). Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am. J. Physiol., 264, H1300-1306.
36. SORRENTINO, V. & VOLPE, P. (1993). Ryanodinc receptors: how many and why? Trends Pharmacol. Sci., 14, 98-103.
37. TAKAI, T., KISHIMOTO, A., IWASA, Y., KAWAHARA, Y., MORI, T. & NISHIZUKA, Y. (1979). Calcium-dependent action of a multi-functional protein kinase by membrane phospholipids. J. Biol. Chem., 254, 3692.
38. 2+ dependent protein kinase. Biochem. Biophys. Res. Commun., 135, 397-402.
39. YANG, S-G., SAIFEDDINE, M., CHUANG, M., SEVERSON, D.L. & HOLLENBERG, M.D. (1991). Diacylglycerol lipase and the contractile action of epidermal growth factor-urogastrone: evidence for distinct signal pathways in a single strip of gastric smooth muscle. Eur. J. Pharmacol., 207, 225-230.